Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
Sell in May and walk away from crypto?!? $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCO $BTCW $GBTC
Sell in May and walk away from crypto?!? $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCO $BTCW $GBTC
0 Day6 Hr16 Min47 Sec
YouTube
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
21 Day6 Hr16 Min47 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
TZ PLUS Cash Back
Latest Feed
May 3, 2024
19 mins ago
MISTRAS Group to Participate in Sidoti Micro-Cap Virtual Investor Conference on May 8-9, 2024
MANAGEMENT PRESENTATION TO BE WEBCAST LIVE AT 10:00 AM ET ON MAY 9, 2024 MANAGEMENT PRESENTATION TO BE WEBCAST LIVE AT 10:00 AM ET ON MAY 9, 2024
175136
News
May 3, 2024
20 mins ago
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
175137
News
May 3, 2024
28 mins ago
XPO (XPO) Q1 2024 Earnings Call Transcript
XPO earnings call for the period ending March 31, 2024.
175138
News
Related on Reddit
Related on X
Related on YouTube
This Is the 1 Stock Powering the Electric Vehicle Revolution: Should You Buy?
There’s a lot of positive momentum for this commodity producer — but also major risks.
Continue Reading
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 3, 2024
19 mins ago
MISTRAS Group to Participate in Sidoti Micro-Cap Virtual Investor Conference on May 8-9, 2024
MANAGEMENT PRESENTATION TO BE WEBCAST LIVE AT 10:00 AM ET ON MAY 9, 2024 MANAGEMENT PRESENTATION TO BE WEBCAST LIVE AT 10:00 AM ET ON MAY 9, 2024
MG
175136
News
May 3, 2024
20 mins ago
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CGON
175137
News
May 3, 2024
28 mins ago
XPO (XPO) Q1 2024 Earnings Call Transcript
XPO earnings call for the period ending March 31, 2024.
XPO
175138
News
Related on Reddit
Related on X
Related on YouTube
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
This Is the 1 Stock Powering the Electric Vehicle Revolution: Should You Buy?
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments